PROTEINA has developed a first-in-class protein-protein interaction (PPI) analysis platform using proprietary 'single-molecule co-immunoprecipitation' technology. Our platform enables quantitative PPI measurements at the single-molecule level, delivering analyses with unparalleled accuracy and speed.
PROTEINA has accumulated extensive know-how in developing assays measuring targeted PPIs as well as the analytic capability to model the efficacy of a drug based on its PPI metrics.
Our mission is to revolutionize protein analysis; developing effective, new approaches to diagnosing diseases and discovering new drug candidates using our novel technology.
For more information regarding PROTEINA, please visit us at www.proteina.co.kr.
Company Details
- Employees
- 28
- Founded
- -
- Address
- 11 Digital-Ro 33-Gil, Guro-Gu, Seoul, Republic Of Korea, Ace Techno Tower 8,suite 1301,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.proteina.co.kr/
- Keywords
- protein science, cancer research, biotechnology, biotechnology laboratory, Single-Molecule Co-Immunoprecipitation Technology, proteomics, protein-protein interactions, PPI, AI Drug Discovery, Affinity Maturation.
- HQ
- Seoul
Proteina Questions
Proteina's website is https://www.proteina.co.kr/
Proteina's LinkedIn profile is https://kr.linkedin.com/company/proteina-co
Proteina has
28 employees.
View email and phone details for 28
employees at Proteina.
Proteina's industry is
Biotechnology Research
Proteina's top competitors are
Nawah Scientific,
Vpix Medical,
Tomocube, Inc.,
Analysis - Egypt,
Prevenotics Inc.,
Proteinea,
Seegene Inc.,
Geninus Inc.,
Spass Inc.,
Proteina For Feeds.
Proteina's categories are Biotechnology Research
Proteina's founding year is 2015
